Pharmaceutical Sciences


Pharmaceutical Sciences: Introduction

Faculty Affiliation

Pharmacy

Degree Programs

Pharmaceutical Sciences

MSc and PhD

  • Fields:
    • Biomolecular Pharmaceutical Sciences;
    • Clinical, Social, and Administrative Pharmaceutical Sciences

Pharmacy

MScPhm

Collaborative Specializations

The following collaborative specializations are available to students in participating degree programs as listed below:

Overview

Pharmaceutical sciences encompasses all aspects of the discovery, development, administration, distribution, and utilization of therapeutic drugs, and the nature, functioning, and dysfunctioning of the biological systems with which drugs interact. As a global leader in pharmaceutical research, the Leslie Dan Faculty of Pharmacy is home to some of the most prominent and distinguished experts in the area of pharmaceutical sciences. The department is centrally located in the heart of Toronto’s Health Sciences Discovery District. Students have the opportunity to conduct their research in collaboration with a wide range of departments at the University of Toronto and nearby world-class teaching hospitals and research institutes to solve some of health science’s most pressing problems.

A degree in Pharmaceutical Sciences can lead to a variety of career opportunities. Graduates have found employment in academia, the pharmaceutical industry, government, community or hospital pharmacy, consulting, and other businesses.

The Graduate Department of Pharmaceutical Sciences offers research opportunities and courses in two fields of study:

  • Biomolecular Pharmaceutical Sciences: drug receptor interactions, molecular biology, electrophysiology, biochemistry, clinical, adverse drug reactions, drug metabolism; pharmaceutical and medicinal chemistry, pharmaceutical formulations, radiopharmaceutical synthesis, drug discovery, biophysical chemistry, basic pharmacokinetics, and clinical research;
  • Clinical, Social, and Administrative Pharmaceutical Sciences: bioethics, clinical pharmacy, drug policy, drug safety, global health and corruption, health economics, health policy, health services research, pedagogy, pharmacoeconomics, pharmacoepidemiology, pharmacy administration, pharmacy practice, social pharmacy, and social psychology.

Contact and Address

Web: pharmacy.utoronto.ca/programs/graduate-department-pharmaceutical-sciences
Email: phm.grad@utoronto.ca
Telephone: (416) 978-8896
Fax: (416) 978-8511

Graduate Department of Pharmaceutical Sciences
Leslie Dan Faculty of Pharmacy
University of Toronto
144 College Street
Toronto, Ontario M5S 3M2
Canada


Pharmaceutical Sciences: Graduate Faculty

Full Members

Allen, Christine - BSc, PhD
Angers, Stéphane - BSc, PhD
Austin, Zubin - BA, BScPhm, MBA, MEd, MISt, PhD (Academic Director, Centre for Practice Excellence)
Bendayan, Reina - BScPhm
Bonin, Robert - BSc, PhD
Boon, Heather - BScPhm, PhD
Cadarette, Suzanne - BSc, MSc, PhD (Graduate Coordinator)
Chalikian, Tigran - PhD
Cummins, Carolyn - BSc, PhD (Director, Graduate Department of Pharmaceutical Sciences)
Dolovich, Lisa - BScPhm, MSc (Dean)
Gomes, Tara - BSc, MSc, PhD
Grootendorst, Paul - BA, MEc, PhD
Guilcher, Sara - BSc, MSc, MSc(PT), PhD
Hampson, David - BSc, MSc, PhD
Heerklotz, Heiko - PhD
Henderson, Jeffrey - BA, PhD
Ito, Shinya - MD, BM
Kelley, Shana - BA, PhD
Kohler, Jillian - BA, MA, PhD
Kotra, Lakshmi - BScPhm, PhD
Lee, Ping - BSChE, PhD
Macgregor, Robert - BSc, PhD
MacKeigan, Linda - BScPhm, PhD
Mamdani, Muhammad - MA, MPH
McCarthy, Lisa - BScPhm, MSc
Moraes, Theo - MD
Pang, Sandy - BSc, BSc, PhD, PhD
Papadimitropoulos, Emmanuel - BSc, BSP, MScPhm, PhD
Pardee, Keith Ian - BSc, MSc, PhD
Pennefather, Peter - BSc, PhD
Piquette-Miller, Micheline - BScPhm, PhD (Associate Dean, Research)
Reilly, Raymond - BScPhm, MScPhm, PhD (Director, Centre for Pharmaceutical Oncology)
Seto, Winnie - BScPhm, MSc
Sproule, Beth - BScPhm
Taddio, Anna - BScPhm, MSc, PhD
Tadrous, Mina - MSc, PhD
Thompson, Alison - BA, MA, PhD
Uetrecht, Jack - BSc, MD, MSc, PhD
Wells, Peter - BScPhm
Wong, William Wai Lun - BSc, MCS, PhD
Wu, Shirley X.Y. - BSc, MSc, PhD
Zheng, Gang - MSc, PhD

Associate Members

Bozinoff, Nikki - MD
Burden, Andrea Michelle - BS, MA, PhD
Burry, Lisa - BScPhm
Chen, Eric - BSc, MD, PhD
Chit, Ayman - PhD
Chung, Erin - BSc, BScPhm, MSc, PhD
Chung, Peter - MD
Corson, Tim - BSc, MSc, PhD
Crown, Natalie - BScPhm
De Lannoy, Ines A.M. - BScPhm, PhD
Dubins, David - BSc, PhD
Grundy, Quinn - BScN, PhD
Ho, Certina - BScPhm, MEd, MISt, PhD
Katz, Joel - MA, PhD
Kellar, Jamie - BSc, BScPhm, PhD (Associate Dean, Academic)
Kim, Sandra - MD, MSc
Labouta, Hagar - BSc, MSc, PhD
Lake, Jennifer - BSc
Lexchin, Joel - BSc, MD, MSc
Li, Bowen - BScPhm, PhD
Poda, Gennadiy - MSc, PhD
Rochon, Paula - MD
So, Miranda - BScPhm
Steenhof, Naomi - BEd, BScPhm, MHPE, PhD
Sun, Hong-Shuo - MSc, DrMed, DPhil
Swidrovich, Jaris - BSP
Tseng, Alice - BScPhm
Uehling, David - BSc, PhD
Yamashita, Sharon - BScPhm


Pharmaceutical Sciences: Pharmaceutical Sciences MSc

The Graduate Department of Pharmaceutical Sciences at the Leslie Dan Faculty of Pharmacy offers students in the physical, biological, clinical, health, and social sciences a challenging and rewarding research-intensive program leading to the Master of Science (MSc) degree. The result is an educational program that encourages multidisciplinary approaches to problem-solving and collaboration between students and faculty members. Graduate students are immersed in a challenging program that equips them with new ways of thinking and provides them with multiple tools to solve problems.

The MSc program can be taken on a full-time or part-time basis. Admission and program requirements are the same for the full-time and part-time options. A limited number of students will be admitted to the part-time option.

MSc Program

Minimum Admission Requirements

  • Applicants are admitted under the General Regulations of the School of Graduate Studies. Applicants must also satisfy the Graduate Department of Pharmaceutical Sciences' additional admission requirements stated below.

  • An appropriate bachelor's degree from a recognized university with at least a mid-B average in each of the last two years of undergraduate study.

  • The Pharmaceutical Sciences Graduate Admissions Committee considers the applicant's background and accomplishments, academic standing, and financial support from the potential supervisor.

  • Applicants whose primary language is not English and who graduated from a university where the language of instruction and examination is not English, must demonstrate facility in the English language through the successful completion of one of the following English-language proficiency tests:

    • Test of English as a Foreign Language (TOEFL) with the following minimum scores:

      • paper-based TOEFL: 600 and 5 on the Test of Written English (TWE)

      • Internet-based TOEFL: 100/120 and 22/30 on the writing and speaking sections.

    • International English Language Testing System (IELTS): a score of 7.0 (Academic) with at least 6.5 in each component.

    • The Certificate of Proficiency in English (COPE): a score of 76, with at least 22 in each component and 32 in the writing component.

    • Academic Preparation Course: a final grade of B in Level 60.

  • If the undergraduate degree was not obtained from a recognized Canadian or US university, the applicant must write and achieve scores at the 50th percentile ranking or better on the Graduate Record Examination (GRE; General Test).

Completion Requirements

  • The MSc is a program of study that provides the appropriate foundation for thesis research. The program depends on the student's background and is planned in consultation with the supervisor and advisory committee, with the approval of the graduate director(s).

  • Coursework. Students must successfully complete a minimum of 1.0 full-course equivalent (FCE).

  • Yearly advisory committee meetings.

  • Attend at least one research ethics workshop (0.0 FCE) for graduate students.

  • One poster presentation to all faculty and graduate students at Graduate Research in Progress (GRIP).

  • Annual attendance at GRIP.

  • Regular attendance at a minimum of eight Pharmaceutical Sciences departmental seminars as well as student group seminars for two years (or less if all other program requirements are completed).

  • An annual oral presentation of the student's own research work is given in the student seminar series.

  • Final seminar to be given during the thesis defence.

  • A thesis based on an approved research problem in an area of pharmaceutical sciences.

Mode of Delivery: In person
Program Length: 6 sessions full-time (typical registration sequence: FWS-FWS); 14 sessions part-time
Time Limit: 3 years full-time; 6 years part-time

 


Pharmaceutical Sciences: Pharmaceutical Sciences PhD

The Graduate Department of Pharmaceutical Sciences offers a challenging and rewarding research-intensive program leading to the PhD degree. Students in the program are immersed in pharmaceutical sciences, working, and collaborating with world-renowned researchers while gaining profound depth and experience in their area of study.

Applicants may enter the PhD program via one of three routes: 1) following completion of an appropriate master's degree; 2) transfer from the University of Toronto's Pharmaceutical Sciences MSc program; or 3) direct entry following completion of an appropriate bachelor's degree. Direct-entry admission spaces are limited.

The department offers a flexible-time PhD program option for selected students. This program benefits professionals with career obligations and whose employment is closely related to their intended area of research. Applicants must meet all the admission requirements for entry to the full-time PhD program in Pharmaceutical Sciences. The program requirements for the flexible-time PhD option are identical to those for the full-time PhD program.

PhD Program

Minimum Admission Requirements

  • Applicants are admitted under the General Regulations of the School of Graduate Studies. Applicants must also satisfy the Graduate Department of Pharmaceutical Sciences' additional admission requirements stated below.

  • Appropriate master's degree from a recognized university with a minimum overall B+ average.

  • The Pharmaceutical Sciences Graduate Admissions Committee considers the applicant's background and accomplishments, academic standing, and financial support from the potential supervisor.

  • Applicants whose primary language is not English and who graduated from a university where the language of instruction and examination is not English, must demonstrate facility in the English language through the successful completion of one of the following English-language proficiency tests:

    • Test of English as a Foreign Language (TOEFL) with the following minimum scores:

      • paper-based TOEFL: 600 and 5 on the Test of Written English (TWE)

      • Internet-based TOEFL: 100/120 and 22/30 on the writing and speaking sections.

    • International English Language Testing System (IELTS): a score of 7.0 (Academic) with at least 6.5 in each component.

    • The Certificate of Proficiency in English (COPE): a score of 76, with at least 22 in each component and 32 in the writing component.

    • Academic Preparation Course: a final grade of B in Level 60.

  • If the undergraduate degree was not obtained from a recognized Canadian or US university, the applicant must write the Graduate Record Examination (GRE; General Test) and achieve scores at the 50th percentile ranking or better on the Verbal and Quantitative components and a minimum score of 5.0 on the Analytical Writing component.

Completion Requirements

  • The PhD is a program of study that provides the appropriate foundation for thesis research. The program depends on the student's background and is planned in consultation with the supervisor and advisory committee, as well as with the approval of the graduate director(s).

  • Coursework. Students normally complete 2.0 full-course equivalents (FCEs) within the first three years of registration.

  • Yearly advisory committee meetings.

  • Successful completion of a PhD qualifying examination within the first 24 months of the program. Students are permitted a second attempt, if necessary, to satisfactorily complete the examination. The format of the examination will include the student giving a 20-minute presentation based on the proposal distributed to the Qualifying Examination Committee, followed by a question period. The student is expected to demonstrate appropriate understanding of the scientific basis of the research, the methodological approaches, and the technical details. Failure to successfully complete the PhD qualifying examination will result in a recommendation for termination of registration in the program.

  • Attend at least one research ethics workshop (0.0 FCE) for graduate students. Students who completed this requirement while registered in the MSc program are not required to attend a second workshop.

  • One poster presentation to all faculty and graduate students at Graduate Research in Progress (GRIP).

  • Annual attendance at GRIP.

  • Regular attendance at a minimum of eight Pharmaceutical Sciences departmental seminars as well as student group seminars in each academic year for four years (or less if all other program requirements are completed).

  • An annual oral presentation of the student's own research work is given in the student seminar series.

  • An open final oral presentation (50 minutes long) immediately prior to a closed thesis defence.

  • A thesis in conformity with University of Toronto regulations, based on research conducted while registered in a PhD program at the University of Toronto.

  • Students must be on campus and participate full-time (including Summer) until all program requirements are completed. Simultaneous registration in another full-time degree program is not allowed.

Mode of Delivery: In person
Program Length: 4 years full-time (typical registration sequence: Continuous)
Time Limit: 6 years full-time

 

PhD Program (Transfer)

Transfer Requirements

  • Students who have a high academic standing and a clearly demonstrated ability to do research at the doctoral level may be eligible to transfer to the PhD program after one year in the MSc program. The student must have completed at least 1.0 full-course equivalent (FCE) with an average grade of A– during Year 1 of the master's program and must have financial support.

  • A transfer from the MSc program to the PhD program occurs normally within 15 to 18 months of the student's first registration in the MSc program.

Completion Requirements

  • Coursework. Students must successfully complete a total of 3.0 full-course equivalents (FCEs).

  • Successful completion of the MSc to PhD transfer examination.

  • The transferred student must complete all remaining course requirements of the MSc program, except the thesis, in addition to the requirements of the PhD program. Credit is given in the doctoral program for research and graduate courses completed prior to the transfer.

  • Yearly advisory committee meetings.

  • Attend at least one research ethics workshop (0.0 FCE) for graduate students. Students who completed this requirement while registered in the MSc program are not required to attend a second workshop.

  • Two poster presentations to all faculty and graduate students at Graduate Research in Progress (GRIP), one of which may be at a peer-reviewed conference upon approval.

  • Annual attendance at GRIP.

  • Regular attendance at a minimum of eight Pharmaceutical Sciences departmental seminars as well as student group seminars in each academic year for four years (or less if all other program requirements are completed).

  • An annual oral presentation of the student's own research work is given in the student seminar series.

  • An open final oral presentation (50 minutes long) immediately prior to a closed thesis defence.

  • A thesis in conformity with University of Toronto regulations, based on research conducted while registered in a PhD program at the University of Toronto.

  • Students must be on campus and participate full-time (including Summer) until all program requirements are completed. Simultaneous registration in another full-time degree program is not allowed.

Mode of Delivery: In person
Program Length: 5 years full-time (typical registration sequence: Continuous)
Time Limit: 7 years full-time

 

PhD Program (Direct-Entry)

Minimum Admission Requirements

  • Applicants are admitted under the General Regulations of the School of Graduate Studies. Applicants must also satisfy the Graduate Department of Pharmaceutical Sciences' additional admission requirements stated below.

  • Under exceptional circumstances, students may be admitted directly to the PhD program with an appropriate bachelor's degree from a recognized university with a minimum A– (80%) average, or its equivalent, in senior-level courses.

  • The Pharmaceutical Sciences Graduate Admissions Committee considers the applicant's background and accomplishments, academic standing, and financial support from the potential supervisor.

  • Applicants whose primary language is not English and who graduated from a university where the language of instruction and examination is not English, must demonstrate facility in the English language through the successful completion of one of the following English-language proficiency tests:

    • Test of English as a Foreign Language (TOEFL) with the following minimum scores:

      • paper-based TOEFL: 600 and 5 on the Test of Written English (TWE)

      • Internet-based TOEFL: 100/120 and 22/30 on the writing and speaking sections.

    • International English Language Testing System (IELTS): a score of 7.0 (Academic) with at least 6.5 in each component.

    • The Certificate of Proficiency in English (COPE): a score of 76, with at least 22 in each component and 32 in the writing component.

    • Academic Preparation Course: a final grade of B in Level 60.

  • If the undergraduate degree was not obtained from a recognized Canadian or US university, the applicant must write the Graduate Record Examination (GRE; General Test) and achieve scores at the 50th percentile ranking or better on the Verbal and Quantitative components and a minimum score of 5.0 on the Analytical Writing component.

Completion Requirements

  • The PhD is a program of study that provides the appropriate foundation for thesis research. The program depends on the student's background and is planned in consultation with the supervisor and advisory committee, as well as with the approval of the graduate chair.

  • Coursework. Students must successfully complete a total of 3.0 full-course equivalents (FCEs).

  • Yearly advisory committee meetings.

  • Successful completion of a PhD qualifying examination within the first 24 months of the program. Students are permitted a second attempt, if necessary, to satisfactorily complete the examination. The format of the examination will include the student giving a 20-minute presentation based on the proposal distributed to the Qualifying Examination Committee, followed by a question period. The student is expected to demonstrate appropriate understanding of the scientific basis of the research, the methodological approaches, and the technical details. Failure to successfully complete the PhD qualifying examination will result in a recommendation for termination of registration in the program.

  • Attend at least one research ethics workshop (0.0 FCE) for graduate students. Students who completed this requirement while registered in the MSc program are not required to attend a second workshop.

  • Two poster presentation(s) to all faculty and graduate students at Graduate Research in Progress (GRIP), one of which may be at a peer-reviewed conference upon approval.

  • Annual attendance at GRIP.

  • Regular attendance at a minimum of eight Pharmaceutical Sciences departmental seminars as well as student group seminars in each academic year for four years (or less if all other program requirements are completed).

  • An annual oral presentation of the student's own research work is given in the student seminar series.

  • An open final oral presentation (50 minutes long) immediately prior to a closed thesis defence.

  • A thesis in conformity with University of Toronto regulations, based on research conducted while registered in a PhD program at the University of Toronto.

  • Students must be on campus and participate full-time (including Summer) until all program requirements are completed. Simultaneous registration in another full-time degree program is not allowed.

Mode of Delivery: In person
Program Length: 5 years full-time (typical registration sequence: Continuous)
Time Limit: 7 years full-time

 

PhD Program (Flexible-Time)

Minimum Admission Requirements

  • Applicants are admitted under the General Regulations of the School of Graduate Studies. Applicants must also satisfy the Graduate Department of Pharmaceutical Sciences' additional admission requirements stated below.

  • Appropriate master's degree from a recognized university with a minimum overall B+ average.

  • The Pharmaceutical Sciences Graduate Admissions Committee considers the applicant's background and accomplishments, academic standing, and financial support from the potential supervisor.

  • Applicants whose primary language is not English and who graduated from a university where the language of instruction and examination is not English are required to write the Test of English as a Foreign Language (TOEFL) with the following minimum scores:

    • paper-based TOEFL: 600 and 5 on the Test of Written English (TWE)

    • Internet-based TOEFL: 100/120 and 22/30 on the writing and speaking sections.

  • If the undergraduate degree was not obtained from a recognized Canadian or US university, the applicant must write the Graduate Record Examination (GRE; General Test) and achieve scores at the 50th percentile ranking or better on the Verbal and Quantitative components and a minimum score of 5.0 on the Analytical Writing component.

  • A letter of support from the employer.

  • The departmental admissions committee reviews the applications; admission is highly selective with preference given to applicants who are members in good standing of a regulated profession or scientific society.

Completion Requirements

  • The PhD is a program of study that provides the appropriate foundation for thesis research. The program depends on the student's background and is planned in consultation with the supervisor and advisory committee, with the approval of the graduate chair.

  • Coursework. Students normally complete a total of 2.0 full-course equivalents (FCEs).

  • Yearly advisory committee meetings.

  • Successful completion of a PhD qualifying examination within the first 32 months of the program. Students are permitted a second attempt, if necessary, to satisfactorily complete the examination. The format of the examination will include the student giving a 20-minute presentation based on the proposal distributed to the Qualifying Examination Committee, followed by a question period. The student is expected to demonstrate appropriate understanding of the scientific basis of the research, the methodological approaches, and the technical details. Failure to successfully complete the PhD qualifying examination will result in a recommendation for termination of registration in the program.

  • Attend at least one research ethics workshop (0.0 FCE) for graduate students. Students who completed this requirement while registered in the MSc program are not required to attend a second workshop.

  • One poster presentation, or two poster presentations by those without a master's degree, to all faculty and graduate students at Graduate Research in Progress (GRIP).

  • Annual attendance at GRIP.

  • Regular attendance at a minimum of eight Pharmaceutical Sciences departmental seminars as well as student group seminars in each academic year for four years. Students whose current professional background is such that they would be deemed to have fulfilled a significant portion of the requirements contained in the department seminar series may be eligible for a reduction of four seminars upon consultation with the Director.

  • An annual oral presentation of the student's own research work is given in the student seminar series.

  • An open final oral presentation (50 minutes long) immediately prior to a closed thesis defence.

  • A thesis in conformity with University of Toronto regulations, based on research conducted while registered in a PhD program at the University of Toronto.

  • Students must ensure that they have adequate time on campus to attend classes and to fulfil the academic requirements.

  • Full-time registration is required for the first four years and thereafter, students may register part-time.

Mode of Delivery: In person
Program Length: 8 years full-time (typical registration sequence: Continuous)
Time Limit: 8 years full-time

 


Pharmaceutical Sciences: Pharmacy MScPhm

The Master of Science in Pharmacy (MScPhm) program is designed to train future academic clinical pharmacist leaders. As members of patient care teams and as pharmacy practice researchers, graduates of the MScPhm program will influence the provision of pharmaceutical care at the patient and population level. As teachers, they will shape the development of current and future pharmacists.

Applicants may apply to the Fall session only.

MScPhm Program (Full-Time and Part-Time Options)

Minimum Admission Requirements

  • Applicants are admitted under the General Regulations of the School of Graduate Studies. Applicants must also satisfy the Graduate Department of Pharmaceutical Sciences' additional admission requirements stated below.

  • Applicants must have status as a pharmacist, based on one of the following:

    • a bachelor's degree from a Canadian pharmacy program accredited by the Canadian Council for Accreditation of Pharmacy Programs (CCAPP) or an American pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE); or

    • a license to practise pharmacy (any Canadian jurisdiction); or

    • a bachelor's degree, or equivalent, from any international pharmacy school and successful completion of the Pharmacy Examining Board of Canada (PEBC) Evaluating Exam.

  • Applicants with pharmacy practice experience, including completion of a Year 1 Pharmacy residency program, are preferred. Applicants must also have an equivalent of a University of Toronto B+ (77 to 79%) in the last two years of study and have identified a primary graduate supervisor for the program.

Completion Requirements

  • Each student's program will be tailored to suit the student's background and interests and will be planned in consultation with the supervisor and graduate advisory committee, with the approval of the graduate chair.

  • Students must complete a minimum of 9.0 full-course equivalents (FCEs) as follows:

    • 1.5 FCEs in required foundational courses:

      • PHM1141H Introduction to Education Theory, Practice, and Scholarship

      • PHM1142H Methods for Patient-Focused and Pharmacy Practice Research

      • PHM1143H Advanced Pharmacy Practice Leadership

    • 1.5 FCEs in elective courses selected in consultation with the supervisor

    • 3.0 FCEs in clinical practicums:

    • research project (3.0 FCEs): PHM9000Y MScPhm Research Practicum.

  • Graduate advisory committee meetings will be held at minimum once each year.

  • One poster presentation given to all faculty and graduate students at Graduate Research in Progress (GRIP).

  • Annual attendance at GRIP.

  • Regular attendance at the graduate departmental and student group seminars — two years for full-time students and four years for part-time students.

  • An annual oral presentation of the student's own research work is given in the student seminar series.

  • An oral presentation of the completed research work will be submitted and assessed at an oral examination.

Mode of Delivery: In person
Program Length: 6 sessions full-time (typical registration sequence: FWS-FWS); 12 sessions part-time
Time Limit: 3 years full-time; 6 years part-time

 


Pharmaceutical Sciences: Pharmaceutical Sciences MSc, PhD Courses

Please consult the department's timetable for courses offered in a given year.

Course CodeCourse Title
Recent Developments in Dosage Form Design
Special Topics in Radiopharmaceuticals II
Biomolecular Interactions and Thermodynamics I
Special Topics in Pharmaceutical Sciences Reading Course
PHM1135HNanomedicines in Oncology
Introduction to Biostatistics
Introduction to Qualitative Research Methods in the Health Sciences
Electronics for Pharmaceutics Applications
Diagnosing Corruption in the Health Sector and Anti-Corruption Policies and Tools
Principles of Synthetic Biology
PHM1141HIntroduction to Education Theory, Practice and Scholarship
PHM1142HMethods for Patient-Focused and Pharmacy Practice Research
PHM1143HAdvanced Pharmacy Practice Leadership
PHM1144HIntroduction to Mixed Methods for Health Services and Policy Research and Pharmaceutical Sciences
PHM1145HIntroduction to Scoping Reviews in Health Sciences
PHM1146HIntroduction to Linear Regression Models
PHM1147HIntroduction to Nucleic Acid Medicines
PHM1148HIntroduction to Pharmacokinetics and its Applications in Modeling
PHM1149HIntroduction to Fundamentals of Drug Discovery
PHM2100HPharmaceutical Sciences Module: Sciences in New Drugs and Biologics
PHM2101HPharmaceutical Sciences Module: Precision in Vitro Diagnostics
PHM2103HPharmaceutical Sciences Module: Addictive Medications — Issues and Insights
PHM2104HPharmaceutical Sciences Module: Advances in Sensory Neuroscience
PHM2105HPharmaceutical Sciences Module: Program Design and Evaluation in Pharmacy
PHM2106HPharmaceutical Sciences Module: Spectroscopy: Absorption and Fluorescence
PHM2107HPharmaceutical Sciences Module: Organizational Theory and Human Resource Management in Pharmacy I
PHM2108HPharmaceutical Sciences Module: Organizational Theory and Human Resource Management in Pharmacy II
PHM2109HPharmaceutical Sciences Module: Clinical Pharmacology of Addictions
PHM2110HPharmaceutical Sciences Module: The Biophysical Chemistry of Lipid Membranes
PHM2111HPharmaceutical Sciences Module: Introduction to Pharmacoepidemiology
PHM2112HPharmaceutical Sciences Module: Introduction to Entrepreneurial Strategy in Life Sciences
Drug Transport Across Biological Membranes
Current Topics in Molecular and Biochemical Toxicology
Molecular and Biochemical Basis of Toxicology
JNP1019HBiomedical Toxicology
JNP1020HInterdisciplinary Toxicology
Introduction to Pharmacoepidemiology
JRH5124HPublic Health Ethics
Multidisciplinary Aspects of Addictions
Clinical Pharmacology
Panel Data Methods for Public Policy Analysis


Pharmaceutical Sciences: Pharmacy MScPhm Courses

Required Foundational Courses

Course CodeCourse Title
Introduction to Education Theory, Practice, and Scholarship
Methods for Patient-Focused and Pharmacy Practice Research
PHM1143HAdvanced Pharmacy Practice Leadership

Practica and Research Project

Course CodeCourse Title
MScPhm Clinical Practicum I
MScPhm Clinical Practicum II
MScPhm Research Practicum

Elective Courses

Course CodeCourse Title
Special Topics in Radiopharmaceuticals II
Special Topics in Pharmaceutical Sciences Reading Course
Introduction to Biostatistics
Introduction to Qualitative Research Methods in the Health Sciences
Electronics for Pharmaceutics Applications
PHM1144HIntroduction to Mixed Methods for Health Services and Policy Research and Pharmaceutical Sciences
PHM1145HIntroduction to Scoping Reviews in Health Sciences
PHM1147HIntroduction to Nucleic Acid Medicines
Principles of Aging
Quantitative Methods in HSR II
JNP1019HBiomedical Toxicology
Interdisciplinary Toxicology
Introduction to Pharmacoepidemiology
Public Health Ethics
Multidisciplinary Aspects of Addictions
Clinical Pharmacology